Quantcast

Industry news that matters to you.  Learn more

Improvement in Prediction of Blood Clots in Cancer Patients

For cancer patients, who have an increased risk of developing venous thromboembolism (VTE) due to a hyperactive blood coagulation system, there is now an enhanced risk model to predict their chance of developing blood clots, according to a recent study published today in Blood, the journal of the American Society of Hematology.

Penn Researchers Receive $12 Million NIH Grant to Develop Personalized Approach to Smoking Cessation

A variety of smoking cessation treatments are currently available for the more than 18 million adult Americans try to quit smoking each year, but success rates vary widely. Despite the importance of quitting smoking, more personalized approaches to smoking cessation treatment are needed to help smokers pick the right method that will work best for them. A major new personalized medicine clinical trial, led by addiction researchers at the University of Pennsylvania, will study how a smokers’ genetic make-up influences their quitting success.

Circadian Granted Key Strategic VEGF-D Patent in USA for Diagnostic Applications

Circadian Technologies has reported that its subsidiary company, Vegenics Limited, has been granted US Patent 7785803 claiming diagnostic kits for the detection of VEGF-D in human samples such as blood.

VEGF-D, a major novel target for cancer and other diseases, has been shown to be a prognostic indicator of survival or disease progression in a number of different cancer types as well as a biomarker for various respiratory diseases.

Micropatch Detects Disease Biomarkers in Skin

Scientists in Australia have built a microneedle device capable of detecting disease-specific proteins directly from the skin.

NPL Scientists Improve Biomarker Detection Technique

Scientists from NPL’s Biotechnology group have developed a new strategy to enable quicker and more precise detection of biomarkers – proteins which indicate disease. The work marks a new research direction for the group, and they hope the technique is an early step towards tools to detect Alzheimer’s and cancer at the molecular level.